Johnson & johnson

Major-Pharmaceuticals

JNJ


One Johnson & Johnson Plaza
New Brunswick , NJ 08933

News

  • Johnson & Johnson added 0.1% to $157.57 after the company reported slightly better-than-expected quarterly results. 

    Revenue in the third quarter increased 6.8% to $21.3 billion from $19.99 billion and net earnings was flat at $4.3 billion and diluted earnings per share edged up 4% to $1.69 from $1.62 a year ago. 

    Sales in the U.S. increased 11.1% to $12 billion from $10.8 billion and international sales rose 1.6% to $9.3 billion from $9.2 billion a year ago. 

    The company revised higher its estimate of non-GAAP annual sales growth estima More

    Oct 17, 2023

  • Johnson & Johnson the pharmaceuticals and consumer products maker, said first quarter revenue increased 5.6% to $24.75 billion. 

    The company swung to a net loss of $68 million from a profit of $5.2 billion and diluted earnings per share swung to ($0.03) from $1.93 a year ago. 

    Adjusted earnings, which excludes special items and amortization expenses,  fell 0.9% to $7.06 billion from $7.2 billion and adjusted diluted earnings per share inched up to $2.68 from $2.67 a year ago. 

    Apr 18, 2023

Executive/
Director

Price

  • Last Close
  • $ 149.27
    $ -0.35 -0.23 %
    Dec 10, 2024
  • 52-Week High/Low
  • $164.59 - $144.51
  • YTD
  • -4.8%

  • Trading Volume
  • 356,967
  • Market Cap Full
  • $ 359.3B
  • Shares Outstanding
  • 2407.3M
    Oct 23, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -3.1% 6.1% 8.8% -7.7% 8.3% -5% 4.4% 3.6% -12.3% 0.9%
Q2 -2.4% 12.9% 6.9% -1.9% 0.2% 4% 0.2% 0.2% 6.7% -0%
Q3 -3.5% -2% -1.1% 14.4% -7.2% 8% -2% -8.6% -5.8% -
Q4 10.9% -1.8% 7.1% -7% 12.2% 5.7% 5.9% 8.8% 1% -
J F M A M J J A S O N D
2024 1.4% 1.6% -2% -0.3% - - - - - - - -
2023 -7.5% -6.2% 1.1% 5.7% -5.2% 6.6% 1.3% -3.5% -3.7% -4.8% 4.3% 1.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    17%1%15%24%-5%13%8%9%3%-11%-5%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.56 1.68 1.83 1.6 1.39 2.17 2.32 1.93 -0.03
Q2 1.71 1.74 1.83 1.45 2.08 1.36 2.35 1.8 1.96
Q3 1.49 1.68 1.90 1.44 0.66 1.33 1.37 1.68 10.21
Q4 1.44 1.58 1.74 1.12 1.5 0.65 1.77 1.32 -
A 6.2 6.7 7.3 5.6 5.6 5.5 7.8 6.7 12.14

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2019 2020 2021 2022 2023 2024
Q1 0.90 0.95 1.01 1.06 1.13 1.19
Q2 0.95 1.01 1.06 1.13 1.19 1.24
Q3 0.95 1.01 1.06 1.13 1.19 1.24
Q4 0.95 1.01 1.06 1.13 1.19 1.24
A 3.75 3.98 4.19 4.45 4.7 4.91
2018 2019 2020 2021 2022 2023
Mar - 2663.1 2634.7 2628.7 2629.3 2604.3
Jun 2682.1 2655.1 2634.6 2633.4 2631.4 2598.7
Sep 2682.8 2639.2 2632.8 2632.5 2629.2 2599
Dec 2682 2631.9 2632.5 2632.6 2614.5 2407.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.5 2.9 3 3.1 3.2
Fixed Asset Turnover 3.2 3.2 3.3 3.5 3.9
Total Asset Turnover 0.5 0.5 0.5 0.5 0.5
Leverage
Debt Ratio 0.5 0.5 0.6 0.6 0.6
Debt – Equity Ratio 0.4 0.4 0.5 0.5 0.5
Interest Coverage 6.8 11.6 9.4 9.3 7.2
Equity multiplier 0.4 0.4 0.4 0.4 0.4